The importance of balancing these processes can be seen by comparing the effects of miR‐675 in mice lacking H19, the non‐coding RNA that makes this miRNA38 with the effect of miR‐675 on myoblast proliferation in vitro and muscle mass in patients with COPD. This evidence concerns the gene H19 and chronic obstructive pulmonary disease.